News
12 May 2026
Frost & Sullivan’s 2026 Global Company of the Year
Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact.
11 September 2026
Avance Clinical Wins ANZCham’s Australia-Taiwan Business Excellence Award in Taiwan
Avance Clinical Taiwan has won the Australia-Taiwan Business Excellence Award at the 2026 Australia New Zealand Chamber of Commerce in Taiwan.
12 May 2026
Frost & Sullivan’s 2026 Global Company of the Year
Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact.
6 June 2025
Avance Clinical Appoints Mark Harvill as Chief Executive Officer
Avance Clinical, a leading CRO for early-phase and Phase II biotech trials in Australia, the APAC region and the U.S., has appointed Mark Harvill as Chief Executive Officer.
15 May 2025
Avance Clinical Honored with Frost & Sullivan’s 2025 Global Customer Value Leadership Award for Transformative Biotech CRO Services
This award recognizes Avance Clinical’s strategic innovation, operational agility, and unwavering commitment to client success in early-phase clinical trials.
27 August 2024
Avance Clinical Wins 2024 Frost & Sullivan Award for Global Biotech CRO Excellence
Avance Clinical, a leading global CRO specializing in clinical trials for the biotech sector, has won the prestigious 2024 Frost & Sullivan Best Practices Customer Value Leadership Award for Global Biotech CRO Excellence.
20 August 2024
Avance Clinical Wins Premier’s Business and Export Awards 2024
Avance Clinical is thrilled to announce that it has again been named as a winner in the prestigious South Australian Premier’s Business and Export Awards 2024. This honor underscores Avance Clinical’s continued commitment to driving innovation and delivering world-class clinical trial solutions to the global market, and comes on the heels of winning the 2023 International Health Exporter of the Year at last year’s awards ceremony.
23 October 2023
Avance Clinical Finalist In The 61st Australian Export Awards 2023
Avance Clinical, the award-winning Australian and North American market leading CRO for biotechs, has again been recognized for its contribution to International Health in the 61st Australian Export Awards 2023.
18 September 2023
CEO Of Avance Clinical Nominated For Executive Of The Year In 2023 Citeline Pharma Intelligence Awards Japan
Avance Clinical is proud to announce that Chief Executive Officer Yvonne Lungershausen has been nominated for Executive of the Year in the 2023 Citeline Pharma Intelligence Awards in Japan.
7 August 2023
Avance Clinical Earns Frost & Sullivan’s 2023 Best Practices Customer Value Leadership Award for Delivering High-quality Clinical Trials Based on Globally Accepted Data
Frost & Sullivan recently researched the Asia-Pacific biotechnology contract research organization industry and, based on its findings, recognizes Avance Clinical with the 2023 Customer Value Leadership Award.
7 August 2023
Avance Clinical Customer Leadership Award Frost & Sullivan Analyst Report
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will visit Seoul in October to expand on collaborative opportunities with South Korean biotech companies.
1 August 2023
Endpoints News Feature: GlobalReady Saving Trial Cost and Time
Frost & Sullivan recently researched the Asia-Pacific biotechnology contract research organization industry and, based on its findings, recognizes Avance Clinical with the 2023 Customer Value Leadership Award.
25 May 2023
Avance Clinical Joins Global Health Summit Campaign for Faster Access to Life-Changing and Life-Saving Therapies
Avance Clinical has been invited to join the Global Health Summit campaign which will be featured on Reuters.
Proven industry
experience & expertise
500+
Studies in the past 5 years
450+
Experienced team members
18k+
Participants past 5 years
30
Years of CRO experience